CASI PHARMACEUTICALS, INC. Debt and Equity Securities, Realized Gain (Loss)
CASI PHARMACEUTICALS, INC. (CASIF) reported Debt and Equity Securities, Realized Gain (Loss) of -$2.01 million for the 12-month period ending 2023-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:DebtAndEquitySecuritiesRealizedGainLoss · last filed 2026-05-15
| Period end | Debt and Equity Securities, Realized Gain (Loss) 12 month |
|---|---|
| 2023-12-31 | -$2.01M 20-F · filed 2026-05-15 |
| 2021-12-31 | -$865.00K 20-F · filed 2024-03-28 |